Difficult to answer of course. However, there's still execution risk in ROW and NNZ. Interestingly, the valuation model suggests NA rights are worth circa $2bn. So, market seems to only reflect what's 'in the bag' ie NA rights.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4550
-
- There are more pages in this discussion • 6,317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.88 |
Change
0.430(2.10%) |
Mkt cap ! $2.613B |
Open | High | Low | Value | Volume |
$20.56 | $20.88 | $20.54 | $777.5K | 37.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 54 | $20.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.88 | 118 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75 | 20.600 |
3 | 65 | 20.590 |
4 | 216 | 20.580 |
4 | 226 | 20.570 |
5 | 234 | 20.560 |
Price($) | Vol. | No. |
---|---|---|
20.650 | 244 | 6 |
20.660 | 101 | 4 |
20.670 | 271 | 4 |
20.680 | 331 | 4 |
20.690 | 537 | 6 |
Last trade - 10.24am 16/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online